SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Oct-24 6:30 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Oct-24 | Grant | 2,229 | -- | -- | 2% 104.0K to 106.22K | |
05-Jun-24 6:11 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jun-24 | Grant | 13,097 | -- | -- | 15% 89.06K to 102.15K | |
03-Apr-24 5:43 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Apr-24 | Grant | 1,467 | -- | -- | 2% 87.59K to 89.06K | |
04-Jan-24 6:11 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-Jan-24 | Grant | 1,393 | -- | -- | 3% 53.82K to 55.22K | |
18-Dec-23 6:44 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Dec-23 | Sale (Planned) | 20,141 | $9.00 | $181,269.00 | (27%) 73.96K to 53.82K | |
04-Oct-23 5:49 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-Oct-23 | Grant | 1,920 | -- | -- | 3% 72.04K to 73.96K | |
06-Jul-23 6:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jul-23 | Grant | 1,863 | -- | -- | 3% 70.18K to 72.04K | |
21-Jun-23 5:21 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Jun-23 | Grant | 12,612 | -- | -- | 22% 57.57K to 70.18K | |
05-Apr-23 6:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Apr-23 | Grant | 1,996 | -- | -- | 10% 20.57K to 22.56K | |
12-Jul-22 5:01 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 08-Jul-22 | Acquisition (other) | 2,420 | -- | -- | 13% 18.14K to 20.57K | |
16-Jun-22 8:14 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Jun-22 | Grant | 18,145 | -- | -- | 100% 0 to 18.14K | |
09-Dec-21 9:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Dec-21 | Acquisition (other) | 3,599 | -- | -- | 100% 0 to 3.6K |